logo
Plus   Neg
Share
Email

Akebia Therapeutics Inc. (AKBA) Is Rising On Q4 Profit

Akebia Therapeutics Inc. (AKBA) reported fourth quarter EPS of $0.25 after the close Monday, compared to the loss of $0.99 a year ago. Analysts expected a loss of $0.35. The stock is now up 1.28 on 11K shares.

Akebia Therapeutics declined for the bulk of Monday's session and ended the day with a loss of 0.56 at $13.52. The stock finished at the lower end of a month and a half long trading range.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT
>